Literature DB >> 6787931

Effect of imidazole on renal function in unilateral ureteral-obstructed rat kidneys.

J C Strand, B S Edwards, M E Anderson, J C Romero, F G Knox.   

Abstract

Imidazole has been proposed to reverse renal vasoconstriction following unilateral obstruction, presumably through blockade of thromboxane A2 (TXA2) synthesis. We examined this hypothesis in rats subjected to unilateral ureteral obstruction for 24 h by 1) performing renal function studies before and during imidazole infusion, and 2) measuring TXB2 and prostaglandin E2 (PGE2) in urine collected before and during imidazole infusion and the profile of products generated by metabolism of arachidonic acid with renal microsomes in vitro. Imidazole infusion was associated with only a bicarbonaturia in the postobstructed kidney; in contrast, clearance of PAH and inulin, fractional sodium excretion, and bicarbonate excretion were all increased in the contralateral kidney. In the postobstructed and contralateral kidneys, TXB2 excretion was diminished and PGE2 excretion was variable not only following imidazole infusion but after saline infusion as well. The profile of products generated by renal microsomal metabolism of arachidonic acid was similar among obstructed, contralateral, and normal kidneys. These results do not support the proposal that TXA2 is the mediator of renal vasoconstriction following unilateral ureteral obstruction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787931     DOI: 10.1152/ajprenal.1981.240.6.F508

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  [Mechanisms of postobstructive polyuria].

Authors:  H J Kramer
Journal:  Klin Wochenschr       Date:  1985-09-16

2.  Urinary endothelin (ET1) in complete ureteric obstruction in the miniature pig.

Authors:  J P Kelleher; V Shah; M L Godley; A J Wakefield; I Gordon; P G Ransley; M E Snell; R A Risdon
Journal:  Urol Res       Date:  1992

3.  Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.

Authors:  M D McGoon; P M Vanhoutte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.